The document “Appendix 3Y Change of Director’s Interest Notice” was lodged with ASX on 22 November, 2021.
Please click to review the full announcement at ASX.
Home » Appendix 3Y Change of Director’s Interest Notice
The document “Appendix 3Y Change of Director’s Interest Notice” was lodged with ASX on 22 November, 2021.
Please click to review the full announcement at ASX.
MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to report that it
1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan
SINGAPORE, and San Diego, California – Prestige Biopharma, a biopharmaceutical company specializing in innovative antibody therapies, with a strong dedication to tackling pancreatic cancer, and Imagion
We’re on a mission to make cancer more detectable.
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance